Madrigal Pharmaceuticals, Inc. — Form D
Madrigal Pharmaceuticals, Inc. of FORT WASHINGTON, PA, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-28. The offering totals $9.0M, of which $3.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-04-28
- Form: D
- Accession: 0001673226-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $9.0M
- Amount sold: $3.4M
- Remaining: $5.6M
- Investors: 4
- Date of first sale: 2016-04-13
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-262200
Issuer
- Name: Madrigal Pharmaceuticals, Inc.
- CIK: 0001673226
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 500 OFFICE CENTER DRIVE, FORT WASHINGTON, PA, 19034
- Phone: 949-725-4277
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Lionel Carnot | Director | Basel, V8 |
| Fred Craves | Director | San Francisco, CA |
| Rebecca Taub | Director | West Vancouver, A1 |
| Rebecca Taub | Executive Officer | West Vancouver, A1 |
More